Abstract
Summary
Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.
The global Remifentanil Hydrochloride market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2024 and 2030.
In Europe, Remifentanil Hydrochloride key players include GSK, Macfarlan Smith, Abbott, Mylan, Arevipharma, etc. The top five players hold a share about 85%.
UK is the largest market, with a share about 20%, followed by Germany and France, having a total share about 30 percent.
In terms of product, 1mg/Pcs is the largest segment, with a share about 85%. And in terms of application, the largest application is Endotracheal Intubation Operation, followed by Neurosurgery, Outpatient Surgery, Postoperative Analgesia, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Remifentanil Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Remifentanil Hydrochloride.
The Remifentanil Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Remifentanil Hydrochloride market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Remifentanil Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
GSK
Macfarlan Smith
Abbott
Mylan
Arevipharma
AMRI
Segment by Type
1mg/Pcs
2mg/Pcs
5mg/Pcs
Segment by Application
Endotracheal Intubation Operation
Neurosurgery
Outpatient Surgery
Postoperative Analgesia
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Remifentanil Hydrochloride in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Remifentanil Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Remifentanil Hydrochloride sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.
The global Remifentanil Hydrochloride market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2024 and 2030.
In Europe, Remifentanil Hydrochloride key players include GSK, Macfarlan Smith, Abbott, Mylan, Arevipharma, etc. The top five players hold a share about 85%.
UK is the largest market, with a share about 20%, followed by Germany and France, having a total share about 30 percent.
In terms of product, 1mg/Pcs is the largest segment, with a share about 85%. And in terms of application, the largest application is Endotracheal Intubation Operation, followed by Neurosurgery, Outpatient Surgery, Postoperative Analgesia, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Remifentanil Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Remifentanil Hydrochloride.
The Remifentanil Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Remifentanil Hydrochloride market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Remifentanil Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
GSK
Macfarlan Smith
Abbott
Mylan
Arevipharma
AMRI
Segment by Type
1mg/Pcs
2mg/Pcs
5mg/Pcs
Segment by Application
Endotracheal Intubation Operation
Neurosurgery
Outpatient Surgery
Postoperative Analgesia
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Remifentanil Hydrochloride in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Remifentanil Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Remifentanil Hydrochloride sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Table of Contents
1 Study Coverage
1.1 Remifentanil Hydrochloride Product Introduction
1.2 Market by Type
1.2.1 Global Remifentanil Hydrochloride Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 1mg/Pcs
1.2.3 2mg/Pcs
1.2.4 5mg/Pcs
1.3 Market by Application
1.3.1 Global Remifentanil Hydrochloride Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Endotracheal Intubation Operation
1.3.3 Neurosurgery
1.3.4 Outpatient Surgery
1.3.5 Postoperative Analgesia
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Remifentanil Hydrochloride Market Size Estimates and Forecasts
2.1.1 Global Remifentanil Hydrochloride Revenue 2019-2030
2.1.2 Global Remifentanil Hydrochloride Sales 2019-2030
2.2 Remifentanil Hydrochloride Market Size by Region: 2023 Versus 2030
2.3 Remifentanil Hydrochloride Sales by Region (2019-2030)
2.3.1 Global Remifentanil Hydrochloride Sales by Region: 2019-2024
2.3.2 Global Remifentanil Hydrochloride Sales Forecast by Region (2025-2030)
2.3.3 Global Remifentanil Hydrochloride Sales Market Share by Region (2019-2030)
2.4 Remifentanil Hydrochloride Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Remifentanil Hydrochloride Revenue by Region: 2019-2024
2.4.2 Global Remifentanil Hydrochloride Revenue Forecast by Region (2025-2030)
2.4.3 Global Remifentanil Hydrochloride Revenue Market Share by Region (2019-2030)
3 Global Remifentanil Hydrochloride by Manufacturers
3.1 Global Top Remifentanil Hydrochloride Manufacturers by Sales
3.1.1 Global Remifentanil Hydrochloride Sales by Manufacturer (2019-2024)
3.1.2 Global Remifentanil Hydrochloride Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Remifentanil Hydrochloride Manufacturers by Revenue
3.2.1 Global Remifentanil Hydrochloride Revenue by Manufacturer (2019-2024)
3.2.2 Global Remifentanil Hydrochloride Revenue Share by Manufacturer (2019-2024)
3.3 Global Remifentanil Hydrochloride Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Remifentanil Hydrochloride Manufacturers Covered: Ranking by Revenue
3.4.2 Global Remifentanil Hydrochloride Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Remifentanil Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Remifentanil Hydrochloride Manufacturing Base Distribution, Product Type
3.5.1 Remifentanil Hydrochloride Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Remifentanil Hydrochloride Product Type
3.5.3 Date of International Manufacturers Enter into Remifentanil Hydrochloride Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 GSK
4.1.1 GSK Company Information
4.1.2 GSK Description, Business Overview
4.1.3 GSK Remifentanil Hydrochloride Products Offered
4.1.4 GSK Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
4.1.5 GSK Remifentanil Hydrochloride Sales by Product in 2023
4.1.6 GSK Remifentanil Hydrochloride Sales by Application in 2023
4.1.7 GSK Remifentanil Hydrochloride Sales by Geographic Area in 2023
4.1.8 GSK Recent Developments
4.2 Macfarlan Smith
4.2.1 Macfarlan Smith Company Information
4.2.2 Macfarlan Smith Description, Business Overview
4.2.3 Macfarlan Smith Remifentanil Hydrochloride Products Offered
4.2.4 Macfarlan Smith Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Macfarlan Smith Remifentanil Hydrochloride Sales by Product in 2023
4.2.6 Macfarlan Smith Remifentanil Hydrochloride Sales by Application in 2023
4.2.7 Macfarlan Smith Remifentanil Hydrochloride Sales by Geographic Area in 2023
4.2.8 Macfarlan Smith Recent Developments
4.3 Abbott
4.3.1 Abbott Company Information
4.3.2 Abbott Description, Business Overview
4.3.3 Abbott Remifentanil Hydrochloride Products Offered
4.3.4 Abbott Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Abbott Remifentanil Hydrochloride Sales by Product in 2023
4.3.6 Abbott Remifentanil Hydrochloride Sales by Application in 2023
4.3.7 Abbott Remifentanil Hydrochloride Sales by Geographic Area in 2023
4.3.8 Abbott Recent Developments
4.4 Mylan
4.4.1 Mylan Company Information
4.4.2 Mylan Description, Business Overview
4.4.3 Mylan Remifentanil Hydrochloride Products Offered
4.4.4 Mylan Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Mylan Remifentanil Hydrochloride Sales by Product in 2023
4.4.6 Mylan Remifentanil Hydrochloride Sales by Application in 2023
4.4.7 Mylan Remifentanil Hydrochloride Sales by Geographic Area in 2023
4.4.8 Mylan Recent Developments
4.5 Arevipharma
4.5.1 Arevipharma Company Information
4.5.2 Arevipharma Description, Business Overview
4.5.3 Arevipharma Remifentanil Hydrochloride Products Offered
4.5.4 Arevipharma Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Arevipharma Remifentanil Hydrochloride Sales by Product in 2023
4.5.6 Arevipharma Remifentanil Hydrochloride Sales by Application in 2023
4.5.7 Arevipharma Remifentanil Hydrochloride Sales by Geographic Area in 2023
4.5.8 Arevipharma Recent Developments
4.6 AMRI
4.6.1 AMRI Company Information
4.6.2 AMRI Description, Business Overview
4.6.3 AMRI Remifentanil Hydrochloride Products Offered
4.6.4 AMRI Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
4.6.5 AMRI Remifentanil Hydrochloride Sales by Product in 2023
4.6.6 AMRI Remifentanil Hydrochloride Sales by Application in 2023
4.6.7 AMRI Remifentanil Hydrochloride Sales by Geographic Area in 2023
4.6.8 AMRI Recent Development
5 Breakdown Data by Type
5.1 Global Remifentanil Hydrochloride Sales by Type (2019-2030)
5.1.1 Global Remifentanil Hydrochloride Sales by Type (2019-2024)
5.1.2 Global Remifentanil Hydrochloride Sales Forecast by Type (2025-2030)
5.1.3 Global Remifentanil Hydrochloride Sales Market Share by Type (2019-2030)
5.2 Global Remifentanil Hydrochloride Revenue Forecast by Type (2019-2030)
5.2.1 Global Remifentanil Hydrochloride Revenue by Type (2019-2024)
5.2.2 Global Remifentanil Hydrochloride Revenue Forecast by Type (2025-2030)
5.2.3 Global Remifentanil Hydrochloride Revenue Market Share by Type (2019-2030)
5.3 Remifentanil Hydrochloride Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Remifentanil Hydrochloride Sales by Application (2019-2030)
6.1.1 Global Remifentanil Hydrochloride Sales by Application (2019-2024)
6.1.2 Global Remifentanil Hydrochloride Sales Forecast by Application (2025-2030)
6.1.3 Global Remifentanil Hydrochloride Sales Market Share by Application (2019-2030)
6.2 Global Remifentanil Hydrochloride Revenue Forecast by Application (2019-2030)
6.2.1 Global Remifentanil Hydrochloride Revenue by Application (2019-2024)
6.2.2 Global Remifentanil Hydrochloride Revenue Forecast by Application (2025-2030)
6.2.3 Global Remifentanil Hydrochloride Revenue Market Share by Application (2019-2030)
6.3 Remifentanil Hydrochloride Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Remifentanil Hydrochloride Market Size YoY Growth 2019-2030
7.2 North America Remifentanil Hydrochloride Market Facts & Figures by Country
7.2.1 North America Remifentanil Hydrochloride Sales by Country (2019-2030)
7.2.2 North America Remifentanil Hydrochloride Revenue by Country (2019-2030)
7.3 North America Remifentanil Hydrochloride Sales by Type (2019-2024)
7.4 North America Remifentanil Hydrochloride Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Remifentanil Hydrochloride Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Remifentanil Hydrochloride Market Facts & Figures by Region
8.2.1 Asia-Pacific Remifentanil Hydrochloride Sales by Region (2019-2030)
8.2.2 Asia-Pacific Remifentanil Hydrochloride Revenue by Region (2019-2030)
8.3 Asia-Pacific Remifentanil Hydrochloride Sales by Type (2019-2024)
8.4 Asia-Pacific Remifentanil Hydrochloride Sales by Application (2019-2024)
9 Europe
9.1 Europe Remifentanil Hydrochloride Market Size YoY Growth 2019-2030
9.2 Europe Remifentanil Hydrochloride Market Facts & Figures by Country
9.2.1 Europe Remifentanil Hydrochloride Sales by Country (2019-2030)
9.2.2 Europe Remifentanil Hydrochloride Revenue by Country (2019-2030)
9.3 Europe Remifentanil Hydrochloride Sales by Type (2019-2024)
9.4 Europe Remifentanil Hydrochloride Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Remifentanil Hydrochloride Market Size YoY Growth 2019-2030
10.2 Latin America Remifentanil Hydrochloride Market Facts & Figures by Country
10.2.1 Latin America Remifentanil Hydrochloride Sales by Country (2019-2030)
10.2.2 Latin America Remifentanil Hydrochloride Revenue by Country (2019-2030)
10.3 Latin America Remifentanil Hydrochloride Sales by Type (2019-2024)
10.4 Latin America Remifentanil Hydrochloride Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Remifentanil Hydrochloride Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Remifentanil Hydrochloride Market Facts & Figures by Country
11.2.1 Middle East and Africa Remifentanil Hydrochloride Sales by Country (2019-2030)
11.2.2 Middle East and Africa Remifentanil Hydrochloride Revenue by Country (2019-2030)
11.3 Middle East and Africa Remifentanil Hydrochloride Sales by Type (2019-2024)
11.4 Middle East and Africa Remifentanil Hydrochloride Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Remifentanil Hydrochloride Supply Chain Analysis
12.2 Remifentanil Hydrochloride Key Raw Materials and Upstream Suppliers
12.3 Remifentanil Hydrochloride Clients Analysis
12.4 Remifentanil Hydrochloride Sales Channel and Sales Model Analysis
12.4.1 Remifentanil Hydrochloride Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Remifentanil Hydrochloride Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Remifentanil Hydrochloride Distributors
13 Market Dynamics
13.1 Remifentanil Hydrochloride Industry Trends
13.2 Remifentanil Hydrochloride Market Drivers
13.3 Remifentanil Hydrochloride Market Challenges
13.4 Remifentanil Hydrochloride Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer